Human phenylalanine hydroxylase gene expression in kidney and other nonhepatic tissues

Molecular Genetics and Metabolism

Volumn 67, Issue 4, 1999, Pages 308-316

  Lichter Konecki, Uta ^a   Hipke, Christine M ^a   Konecki, David S ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

Brain; Gene expression; Hyperphenylalaninemia (HPA); Kidney; Pancreas; Phenylalanine hydroxylase (PAH); Phenylketonuria (PKU)

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; PHENYLALANINE 4 MONOOXYGENASE;

ARTICLE; BRAIN; CONTROLLED STUDY; DNA SEQUENCE; ENZYME DEFICIENCY; FETUS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPERPHENYLALANINEMIA; LIVER; MENTAL DEFICIENCY; PANCREAS; PHENYLKETONURIA; PRIORITY JOURNAL;

RODENTIA;

EID: 0032839535     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1999.2880     Document Type: Article

References (45)

1. Rao D N, Kaufman S. Purification and state of activation of rat kidney phenylalanine hydroxylase. J Biol Chem. 261:1986;8866-8876.
2. Tourian A, Goddard J, Puck T T. Phenylalanine hydroxylase activity in mammalian cells. J Cell Physiol. 73:1969;159-170.
3. Ayling J E, Pirson W D, Al-Janabi J M, Helfand G D. Kidney phenylalanine hydroxylase from man and rat. Comparison with the liver enzyme. Biochemistry. 13:1974;78-85.
4. Wapnir R A, Hawkins R L, Stevenson J H. Ontogenesis of phenylalanine and tryptophane hydroxylation in rat brain and liver. Biol Neonate. 118:1971;85-93.
5. Hoffbauer R W, Schrempf G. Phenylalanine hydroxylation in cultured fibroblasts from patients with phenylketonuria. Lancet. 2:1976;94.
6. Matalon R, Justice P, Deanching M N. Phenylalanine hydroxylase in human placenta: Novel system for study of phenylketonuria. Lancet. 1:1977;853-854.
7. Murthy L I, Berry H K. Phenylalanine hydroxylase activity in liver from humans and subhuman primates: Its probable absence in kidney. Biochem Med. 12:1975;392-397.
8. Robson K JH, Chandra T, MacGillivray R TA, Woo S LC. Polysome immunoprecipitation of phenylalanine hydroxylase mRNA from rat liver and cloning of its cDNA. Proc Natl Acad Sci USA. 79:1982;4701-4705.
9. Jones M R, Kopple J D, Swendseid M E. Phenylalanine metabolism in uremic and normal man. Kidney Int. 14:1978;169-179.
10. Young G A, Parsons F M. Impairment of phenylalanine hydroxylation in chronic renal insufficiency. Clin Sci Mol Med. 45:1973;89-97.
11. McGee M M, Greengard O, Know W E. The quantitative determination of phenylalanine hydroxylase in rat tissues. Biochem J. 127:1972;669-674.
12. Wang Y, DeMayo J L, Hahn T M, Finegold M J, Konecki D S, Lichter-Konecki U, Woo S LC. Tissue- and development-specific expression of the human phenylalanine hydroxylase/chloramphenicol acetyltransferase fusion gene in transgenic mice. J Biol Chem. 267:1992;15105-15110.
13. Treacy E P, Delente J J, Elkas G, Carter K, Lambert M, Waters P J, Scriver C R. Analysis of phenylalanine hydroxylase genotypes and hyperphenylalaninemia phenotypes using L-[1-C-13]phenylalanine oxidation rates in vivo: A pilot study. Pediatr Res. 42:1997;430-435.
14. Urhammer S A, Moller A M, Nyholm B, Ekstrom C T, Eiberg H, Clausen J O, Hansen T, Pedersen O, Schmitz O. The effect of two frequent amino acid variants of the hepatocyte nuclear factor-1alpha gene on estimates of the pancreatic beta-cell function in Caucasian glucose-tolerant first-degree relatives of type 2 diabetic patients. J Clin Endocrinol Metab. 83:1998;3992-3995.
15. Urhammer S A, Hansen T, Ekstrom C T, Eiberg H, Pedersen O. The Ala/Val98 polymorphism of the hepatocyte nuclear factor-1alpha gene contributes to the interindividual variation in serum C-peptide response during an oral glucose tolerance test: Evidence from studies of 231 glucose-tolerant first degree relatives of type 2 diabetic probands. J Clin Endocrinol Metab. 83:1998;4506-4509.
16. Scriver C R, Kaufman S, Eisensmith E, Woo S LC. The hyperphenylalaninemias. Scriver CR Beaudet AL, Sly WS Valle D. The Metabolic and Molecular Bases of Inherited Disease. 1995;1015-1075 McGraw-Hill, New York.
17. Okano Y, Eisensmith R C, Güttler F, Lichter-Konecki U, Konecki D S, Trefz F K, Dasovich M, Wang T, Henriksen K, Lou H, Woo S LC. Molecular basis of phenotypic heterogeneity in phenylketonuria. N Engl J Med. 324:1991;1232-1238.
18. Kayaalp E, Treacy E, Waters P J, Byck S, Nowacki P, Scriver C R. Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: A metanalysis of genotype-phenotype correlations. Am J Hum Genet. 61:1997;1309-1317.
19. Lichter-Konecki U, Rupp A, Konecki D S, Trefz F K, Schmidt H, Burgard P. Relation between phenylalanine hydroxylase genotypes and phenotypic parameters of diagnosis and treatment of hyperphenylalaninaemic disorders. J Inherit Metab Dis. 17:1994;362-365.
20. Konecki D S, Wang Y, Trefz F K, Lichter-Konecki U, Woo S LC. Structural characterization of the 5′-regions of the human phenylalanine hydroxylase gene. Biochemistry. 31:1992;8363-8368.
21. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
22. Kaestner K H, Lee K H, Schlondorff J, Hiemisch H, Monaghan A P, Schutz G. Six novel members of the murine forkhead gene are developmentally regulated. Proc Natl Acad Sci USA. 90:1993;7628-7631.
23. Wilkinson D G. In situ Hybridisation. A Practical Approach. 1992;Oxford Univ Press.
24. Monaghan A P, Grau E, Bock D, Schütz G. The mouse homolog of the orphan nuclear receptor tailless is expressed in the developing forebrain. Development. 121:1995;839-853.
25. Jennings I G, Russell R GM, Armarego W LF, Cotton R GH. Functional analysis of the effect of monoclonal antibodies on monkey liver phenylalanine hydroxylase. Biochem J. 235:1986;133-138.
26. Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
27. Ledley F D, Grenett H E, DiLella A G, Kwok S CM, Woo S LC. Gene transfer and expression of human phenylalanine hydroxylase. Science. 228:1985;77-79.
28. Døskeland A P, Døskeland S O, Ogreid D, Flatmark T. The effect of ligands of phenylalanine 4-monooxygenase on the cAMP-dependent phosphorylation of the enzyme. J Biol Chem. 259:1984;11242-11248.
29. Konecki D S, Foetisch K, Zimmer K-P, Schlotter M, Lichter-Konecki U. An alternatively spliced form of the human lysosome-associated membrane protein-2 gene is expressed in a tissue-specific manner. Biochem Biophys Res Commun. 215:1995;757-767.
30. Kaufman S. The phenylalanine hydroxylating system. Adv Enzymol. 67:1993;77-264.
31. Niederwieser A, Curtius H C, Wang M, Leupold D. Atypical phenylketonuria with defective biopterin metabolism. Monotherapy with tetrahydrobiopterin or sepiapterin, screening and study of biosynthesis in man. Eur J Pediatr. 138:1982;110-112.
32. Hoshiga M, Hatakeyama K, Watanabe M, Shimada M, Kagamiyama H. Autoradiographic distribution of [14C]tetrahydrobiopterin and its developmental change in mice. J Pharmacol Exp Ther. 267:1993;971-978.
33. Askin D, Green A K, Dickson A J, Fisher M J. Phenylalanine hydroxylation in isolated rat kidney tubules. Int J Biochem. 22:1990;107-114.
34. Greengard O, Delvalle J A. The regulation of phenylalanine hydroxylase in rat tissues in vivo. Substrate- and cortisol-induced elevations in phenylalanine hydroxylase activity. Biochem J. 154:1976;619-624.
35. Knappskog P M, Flatmark T, Aarden J M, Haavik J, Martinez A. Structure/function relationships in human phenylalanine hydroxylase. Effect of terminal deletions on the oligomerization, activation and cooperativity of substrate binding to the enzyme. Eur J Biochem. 242:1996;813-821.
36. Fusetti F, Erlandsen H, Flatmark T, Stevens R C. Structure of tetrameric human phenylalanine hydroxylase and its implications for phenylketonuria. J Biol Chem. 273:1998;16962-16967.
37. Parniak M A. Organization of the catalytic and regulatory sites of rat liver phenylalanine hydroxylase. Curtius H-C, Blau N. Unconjugated Pterins and Related Biogenic Amines. 1987;327-337 Water de Gruyter, Berlin.
38. Abita J P, Blandin-Savoja F, Rey F. Phenylalanine 4-monooxygenase from human liver. Methods Enzymol. 412:1987;27-35.
39. Døskeland A P, Martinez A, Knappskog P M, Flatmark T. Phosphorylation of recombinant human phenylalanine hydroxylase: effect on catalytic activity, substrate activation and protection against non-specific cleavage of the fusion protein by restriction protease. Biochem J. 313:1996;409-414.
40. Trefz F K, Burgard P, König T, Goebel-Schreiner B, Lichter-Konecki U, Konecki D, Schmidt E, Schmidt H, Bickel H. Genotype-phenotype correlations in phenylketonuria. Clin Chim Acta. 217:1993;15-21.
41. Waters P J, Parniak M A, Nowacki P, Scriver C R. In vitro expression analysis of mutations in phenylalanine hydroxylase: Linking genotype to phenotype and structure to function. Hum Mutat. 11:1998;4-17.
42. Blumenfeld M, Maury M, Chouard T, Yaniv M, Condamine H. Hepatic nuclear factor 1 (HNF1) shows a wider distribution than products of its known target genes in developing mouse. Development. 113:1991;589-599.
43. Pontoglio M, Barra J, Hadchouel M, Doyen A, Kress C, Bach J P, Babinet C, Yaniv M. Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell. 84:1996;575-585.
44. Lei X D, Kaufman S. Identification of hepatic nuclear factor 1 binding sites in the 5′ flanking region of the human phenylalanine hydroxylase gene: Implication of a dual function of phenylalanine hydroxylase stimulator in the phenylalanine hydroxylation system. Proc Natl Acad Sci USA. 95:1998;1500-1504.
45. Grompe M, Al-Dhalimy M, Overturf K, Finegold M. Hepatic repopulation by adult murine pancreatic liver stem cells. Am J Hum Genet. 63:1998;A3.